GTHP — GUIDED THERAPEUTICS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 924515 ·
Last close
$0.19
Market Cap
$18.34M
52W High
$0.39
52W Low
$0.17
ADV30
17,153
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -302,000 | -500,000 | 1,604,000 | 369,000 | 6,780,000 |
| Dec 2025 | 590,000 | 458,000 | -710,000 | -1,218,000 | 1,324,000 | 63,000 | 7,330,000 |
| Sep 2025 | 60,000 | 35,000 | -485,000 | -742,000 | 903,000 | 87,000 | 6,549,000 |
| Jun 2025 | 117,000 | 79,000 | -763,000 | -811,000 | 940,000 | 185,000 | 6,412,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,068,000
Investing CF
$0
Financing CF
$745,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-157,055,000
Inventory
$448,000
Receivables
$4,000
ST Investments
—
EBIT TTM
$-2,581,000
Pretax Income TTM
$-3,198,000
Interest Exp TTM
$617,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$767,000
EBITDA
$-2,250,000
Free Cash Flow
$-929,625
Enterprise Value
$20,509,722
Total Cash
$369,000
Total Debt
$2,785,000
Shares Out
96,537,349
Trailing EPS
$-0.04
Book Value
$-0.09
ROE
—
ROA
-109.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 767,000 | -2,372,000 | -3,196,000 | 1,324,000 | 7,330,000 | — | -1,068,000 |
| Dec 2024 | 7,000 | -2,108,000 | -2,417,000 | 1,378,000 | 6,267,000 | — | -1,119,000 |
| Dec 2023 | 98,000 | -3,457,000 | -3,489,000 | 1,669,000 | 5,475,000 | — | -1,746,000 |
| Dec 2022 | 13,000 | -3,333,000 | -4,341,000 | 3,366,000 | 6,249,000 | — | -1,479,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICCM | IceCure Medical Ltd. | $18.40M | $0.23 | — |
| IRIX | IRIDEX CORP | $18.10M | $1.04 | — |
| OSRH | OSR Holdings, Inc. | $17.38M | $0.50 | — |
| LFWD | Lifeward Ltd. | $19.39M | $6.98 | — |
| ADGM | Adagio Medical Holdings, Inc. | $16.66M | $0.75 | — |
News headlines (Yahoo Finance, 1h cache)
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
2026-03-31 13:00 · Yahoo
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
2025-12-17 14:00 · Yahoo
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
2025-12-11 14:00 · Yahoo
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
2025-11-19 14:00 · Yahoo
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
2025-08-19 13:00 · Yahoo
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
2025-08-13 13:00 · Yahoo
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
2025-07-02 13:00 · Yahoo
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
2025-06-10 13:00 · Yahoo
Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
2025-05-27 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.